Association Between Body Composition and Development of Glucose Intolerance after Allogeneic Hematopoietic Cell Transplantation.

TitleAssociation Between Body Composition and Development of Glucose Intolerance after Allogeneic Hematopoietic Cell Transplantation.
Publication TypeJournal Article
Year of Publication2022
AuthorsBhandari R, Teh JBerano, He T, Peng K, Iukuridze A, Atencio L, Nakamura R, Mostoufi-Moab S, McCormack S, Lee K, F Wong L, Armenian SH
JournalCancer Epidemiol Biomarkers Prev
PaginationOF1-OF7
Date Published2022 Jul 06
ISSN1538-7755
Abstract

BACKGROUND: Allogeneic hematopoietic cell transplantation (HCT) recipients have increased risk of developing glucose intolerance and diabetes mellitus (DM). The strongest risk factor for glucose intolerance is being overweight/obese, as determined by body mass index (BMI), which does not account for differences in body composition. We examined the association between body composition measures from pre-HCT CT and early-onset (≤30 days) de novo glucose intolerance after HCT, and determined its impact on nonrelapse mortality (NRM).

METHODS: This study included 749 patients without pre-HCT DM. Skeletal muscle loss [abnormal skeletal muscle gauge (SMG)] and abnormal visceral adiposity (VA) were defined by sex-specific tertiles. Fine-Gray proportional subdistribution HR estimates and 95% confidence intervals (CI) were obtained to determine the association between muscle loss and VA and development of glucose intolerance. 1 year NRM was calculated for patients alive at day 30.

RESULTS: Median age at HCT was 50.2 years. By day 30, 8.1% of patients developed glucose intolerance and 731 remained alive. In multivariable analysis, abnormal SMG was associated with increased risk of glucose intolerance in nonoverweight (BMI < 25 kg/m2) patients (HR = 3.00; 95% CI, 1.15-7.81; P = 0.024); abnormal VA was associated with increased risk of glucose intolerance in overweight/obese patients (HR = 2.26; 95% CI, 1.24-4.12; P = 0.008). Glucose intolerance was independently associated with NRM (HR = 1.88; 95% CI, 1.05-3.39; P = 0.035).

CONCLUSIONS: Abnormal SMG and VA were associated with glucose intolerance in nonoverweight and overweight/obese patients, respectively, which contributed to increased risk of 1 year NRM.

IMPACT: This information may guide personalized interventions to decrease the risk of adverse outcomes after HCT.

DOI10.1158/1055-9965.EPI-21-1449
Alternate JournalCancer Epidemiol Biomarkers Prev
PubMed ID35797113